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 Iron deficiency anaemia
a b s t r a c t
Background: Chronic anaemia mainly thalassemia and sickle cell anaemia are inherited
disorders of haemoglobin. Presently about 7% of the world's populations are carriers of
a potentially pathological haemoglobin gene. Sickle cell disease is a common haemoglo-
binopathy in Nigeria but recently cases of b-thalassemia traits are becoming prominent.
This study aimed at screening for b-thalassemia in adults and children with chronic
anaemia in Nigeria by assessing the patients’ level of haemoglobin F, haemoglobin A2
and red cell indices. Materials and methods: Haemoglobin F and HbA2 were determined
in the chronic anaemia patients by Alkaline Denaturation Method and Beta-Thal HbA2
Quick Column Procedure respectively. Haemoglobin genotype was determined by Haemo-
globin Electrophoresis at alkaline medium while Complete Blood count was estimated
using Sysmex KX-2IN Autoanalyser. Results: The mean HbF, HbA2, HCT, MCV, MCH and
MCHC of the children and adults are 2.56  0.46 and 2.45  0.87 (%); 2.05  0.25 and 1.89
 0.60 (%); 0.21  0.31 and 0.21  0.36 (L/L); 81.58  12.59 and 78.69  14.11 (fL); 22.74  5.39
and 23.07  7.36 (pg); 27.52  3.84 and 31.23  14.32 (g/l) respectively. Four percent (2 sub-
jects) of each adult and children population had increased HbF level (>1.5%) and HbA2
levels (>2.8%) and these subjects are composed of 2 children with haemoglobin genotype
AA and two adult with haemoglobin genotypes SS. Conclusions: The outcome of this
study reiterates the emergence of b-thalassemia traits and iron deficiency anaemia in
different parts of Nigeria irrespective of their haemoglobin genotype status. This requires
adequate specialized intervention for their diagnosis and treatment. There is therefore
the need for subsequent molecular analysis to determine the b-thalassemia genes pre-
sent in the studied community.
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logical parameters
Variable Mean  SD Mean  SD P value
Children Adults
PCV (l/l) 0.21  0.31 0.21  0.36 0.773
MCV (fL) 81.58  12.59 78.69  14.11 0.283
MCH (pg) 22.74  5.39 23.07  7.36 0.796
MCHC (g/l) 27.52  3.84 31.23  14.32 0.081
HbF (%) 2.56  0.46 2.45  0.85 0.442
HbA2 (%) 2.05  0.25 1.89  0.60 0.181Introduction
Anaemia is one of the most common disorders affecting
humans in the world today and it still remains a problem
not only in the developing countries, but also in devel-
oped countries [1]. Chronic anaemia is a form of anaemia
which usually persists longer than two to six months.
There are more than 400 possible causes of anaemia;
effective treatment therefore depends on the underlying
cause [2].
Inherited haemoglobin disorders are the most common
genetic disorders, estimate by the World Health Organiza-
tion to be carried by approximately 7% of the world's
population [1]. Some of these diseases, particularly sickle-
cell anaemia, and the more severe forms of thalassemia,
cause life-threatening medical emergencies, chronic disabil-
ity to families, and a major drain on health resources [3].
Beta thalassemias which are due to mutations in the
HBB gene on chromosome 11, inherited in an autosomal-
recessive fashion [4] results in reduced synthesis of beta
chains, and a relative excess of a chains causing damage to
the red cells leading to profound anaemia which in turn
causes expansion of the ineffective marrow, with severe
effects on development, bone formation, and growth [5].
Sickle beta-thalassemia (S/beta-thalassemia) is a condi-
tion which results from coinheritance of a sickle cell gene
and a beta-thalassemia gene. The clinical phenotype
depends on the type of beta-thalassemia gene (beta (+) or
beta (8)) inherited. The clinical and haematological features
have several similarities and these sometimes pose difficulty
in correct diagnosis of the condition. A definitive diagnosis is
required in order to initiate early supportive treatment in
patients with homozygous sickle cell disease (SS disease)
and to define the later clinical course [6].
In b8/b8, the haemoglobin produced is mainly HbF
(98%) and HbA2 (1.5%). There is a small amount of HbA
(0.5%) when the genotype is b8/b+ or b+b+. HbS/b8 thalas-
semia resembles sickle cell anaemia. However, the MCV,
and MCH are lower in HbS/b8 and HbA2 is raised [7]. This
study screened for b-thalassemia by determining and
correlating the haemoglobin A2, haemoglobin F levels and




A total of 100 chronic anaemic patients (comprising of
50 children ages Birth to 15 years and 50 adults ages 16 years
and above) attending Haematology clinic or hospitalised in
various male, female and children wards of Ladoke Akintola
University Of Technology Teaching Hospital, Osogbo, Nigeria
were recruited for this study within a period of 6 months.
Informed consent was obtained from the patients or their
parent. Ethical clearance was obtained from the Ethical
committee of the Ladoke Akintola University of Technology
Teaching Hospital, Osogbo, Osun State.Methods
Five ml of venous blood was collected into an EDTA
bottle. The Complete blood count (Haematocrit, MCV and
MCH) was estimated with Sysmex KX-21N autoanalyser
[8]. Cellulose Acetate Electrophoresis was performed to
determine various genotypes of the patients [9]; HbF was
estimated using the Alkaline Denaturation Method [10]
while HbA2 was estimated with the Beta-Thal HbA2 Quick
Column Procedure by Helena Laboratories (Catalogue No.
5341) [11, 12]. The Beta-Thal HbA2 Quick Column is
quantitative method in which 50 ml of whole blood col-
lected was added to 200 ml of haemolysates reagent-C
provided, mixed vigorously and allowed to stand at least
5 minutes for complete hemolysis to occur. Then 100 ml of
the sample haemolysate was slowly applied to the Sickle-
Thal quick column and another 100 ml of the sample
preparation was added to a large collection tube labeled
Total Fraction (TF) and filled up to 15 ml mark. The
haemolysates appeared glossy when viewed from above
until the sample is completely absorbed by the resin.
Then 3.0 mL of Sickle-Thal A2 developer (provided by the
manufacturer) was slowly applied to the column, allowed
passing through the column into a small collection tube
(approximately 30 minutes to 1 hour) and this eluate
contains the HbA2. The percentage of HbA2 was deter-
mined spectrophotometrically at 415 nm by measuring the
absorbance of each eluate and each Total Fraction (TF).
Subjects with increased HbF (>1.5%) and increased HbA2
(>2.8%, according to the Beta-Thal HbA2 Quick Column
Procedure Manufacturer) were considered to be indicative of
b-thalassemia trait. Statistical analysis was done using the
SPSS version 20. P < 0.05 denotes a significant difference.
Results
A total of 100 subjects comprising of 50 adults (28 males and
22 females) and 50 (26 males and 24 females) children with
packed cell volume less than 25% were used in this study.
Table I shows the mean and standard deviation (SD) of
the studied parameters and age. The mean HbF levels of the
children and adults are 2.56  0.46 and 2.45  0.87 while
their mean HbA2 levels are 2.05  0.25 and 1.89  0.60
respectively.
Table II shows the cross tabulation of HbF and HbA2
values in the children and Adult patients. The data obtained
Table II – Cross tabulation of HbA2 and HbF in the children
and adult patients
HbA2 P value
HbA2 <2.8% HbA2 >2.8%
Children
HbF<1.5 31 0 0.003
HbF 1.5 17 2
Adults
HbF <1.5 34 0
HbF 1.5 14 2
Table III – Comparison of HbA2 levels with the MCV, MCH
values in the Children and Adult subjects
HbA2 P value
A2 <1.8% A2 >1.8%
Children
<MCV (fL), MCH (pg)* 14 7 0.001
>MCV (fL), MCH (pg)** 21 8
Total 35 15
Adults
<MCV (fL), MCH (pg) 8 6 0.001
>MCV (fL), MCH (pg) 29 7
Total 37 13
* <MCV (fL), MCH (pg) – decreased level of both mean cell volume
(in femtolitre) and mean cell haemoglobin (in picogram).
** >MCV (fL), MCH (pg) – increased level of both mean cell volume
(in femtolitre) and mean cell haemoglobin (in picogram).
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<2.8%, 17 children had HbF 1.5% and HbA2 <2.8% with just
2 children having HbF level >1.5% and HbA2 levels >2.8%
while 34 adult subjects had HbF level <1.5% and HbA2 <
2.8%, 14 had HbF 1.5% and HbA2 <2.8% with 2 adult
subjects having HbF level >1.5% and HbA2 levels >2.8%.
The relationship between the HbF and HbA2 levels with
the various Haemoglobin variants is represented in Figure 1.
Subjects with reduced HbF (<1.5%) are 22 HbAA, 7 HbAS,
5HbSS adults and 21 HbAA, 7 HbAS and 3HbSS children
while those with increased HbF (>1.5%) 12 HbAA, 1 HbAS,Fig. 1 – HbF, HbA2 levels and the different6HbSS adults and 26 HbAA, 15 HbAS and 7HbSS children.
Also, subjects with reduced HbA2 (<2.8%) are 34 HbAA,
8 HbAS, 6HbSS adults and 26 HbAA, 15 HbAS and 7HbSS
children while those with increased HbA2 (>2.8%) are 2 SS
adult and 2 AS children (Table III). haemoglobin variants of the subjects
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b-thalassemia is a major inherited haemoglobin disorder
which is being misdiagnosed in this part of the world
especially when presenting with major symptoms such as
chronic anaemia. A diagnosis of thalassemia may be
suspected based on complete blood count (CBC) and
peripheral blood film examination, Haemoglobin Electro-
phoresis, Isoelectric focusing, Haemoglobin A2 and Haemo-
globin F quantification and Genetic testing [13]. However
CBC, Haemoglobin Electrophoresis, Haemoglobin A2 and
Haemoglobin F quantification methods that are readily
available in this setting were used for this study. It should
also be noted that while molecular methods are now being
used for the diagnosis of thalassemia, they are used for
confirmation after the quantitation of HbA2 and estimation
of HbF levels as was done in this study and this criteria
are also being used in resolving difficult cases. Therefore,
our diagnostic methods and procedures are appropriate in
this setting.
This study therefore screens for b-thalassemia in chronic
anaemic adults and children based on increased level of
HbF and HbA2 and reduced red cell indices. Out of a total of
100 chronic anaemic subjects recruited for this study,
4 individuals comprising of 2 adults and 2 children had
increased HbA2 (>2.8%) and HbF (>1.5%) levels which is
indicative of b-Thalassemia trait according to Kotila et al.
[14]. A similar study carried out by Omoti in 2005, in which
HbA2 and HbF were estimated by modified Betke and micro
column method respectively, in sickle cell anaemia patients
was observed to have 6 patients (2.4%) out of 246 patients
with increased HbA2 (>3.5%) and HbF (>1.5%) [15].
HbSS subjects were observed to have the highest mean
 SD HbF level (2.09  1.94%), followed by HbSC (0.85
 0.54%), HbAA (0.69  0.46%), HbAS (0.52  0.31%), and
HbAC (0.57  0.26%), with statistically significant differ-
ences among the haemoglobin types (P < 0.05) in a study
conducted by Akanni et al. in 2011 [16]. This study also
shows that the 4 subjects with thalassemia features
(increased HbA2 and HbF levels) in this study are composed
of 2 female children with haemoglobin genotype AA,
a male and a female adult with haemoglobin genotypes SS
respectively.
In addition, increased HbF level (>1.5%) in this study was
found to be higher in females than in males, with female
HbAS subjects having the highest mean HbF level. Similar
work was done by Mason et al. in 1982 [17], whereby the
mean HbF levels was higher in females than in males, with
HbSS and HbSC subjects having the highest mean HbF level.
In addition, Mason's study in 1992 also shows that after the
age of 10, HbF levels were consistently higher in females
than in males.
The red cell indices play important roles and are
widely used in the classification of anaemia. They are
used in screening programme for the detection of carriers
of b+ thalassemia in population surveys. However it has
been discovered that individual values for MCV, MCH and
MCHC occasionally overlap with those in the normal
population thereby casting doubt on the adequacy ofthese criteria alone in identifying all cases of the hetero-
zygous thalassemia in various haemoglobin variants [18].
The lowest level of HbA2 is in association with the most
severe Iron deficiency anaemia. Iron and folate deficiency
each suppressed HbA2 levels in b-thalassemia heterozygous,
microcytosis which is MCV <65.9 fl, HbA2 (range 1.3–1.8) was
useful in the differential diagnosis of Iron deficiency anae-
mia [19]. Hence, thalassemia, iron deficiency anaemia, and
sickle cell disease remain the leading chronic forms of
anaemia depending on the levels of foetal haemoglobin and
haemoglobin A2. Out of the 100 subjects analyzed, 14 chil-
dren and 8 adults had reduced MCV (<77 fl), MCH (<21 pg)
and reduced HbA2 (1.3–1.8% according to the Helena Beta-
Thal HbA2 Quick Column) and these subjects are categorized
to be Iron deficient anaemic subjects.
HbF and HbA2 levels in conjunction with the red cell
indices remains a reliable diagnostic tool in b-thalassemia
diagnosis provided adequate diagnostic methods are
engaged.
In conclusion, the result of the screening shows
increased HbA2 and HbF levels in 2 adult and children
subjects each with different haemoglobin variants AA and
SS. Further genetic tests are recommended to identify the
mutations in those with features of thalassemia (with
increased HbA2 and HbF) among these patients who have
already developed chronic anaemia.
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